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Margatoxin (MgTX), a 39 amino acid peptide present in the venom of the new world 
scorpion Centruroides marguritatus, is a potent inhibitor of the voltage-gated potassium 
channel (K,1.3) in human peripheral T lymphocytes. Peptide analogs corresponding to the 
amino acid segments that are located at the rat K”1.3 putative binding site for the ion 
channel blockers were synthesized. Gas phase noncovalent complexes of the synthetic 
analogs of the rat K”1.3 peptide ligands with MgTX were detected using ion-spray mass 
spectrometry. (J Am Sot Mass Spectrum 1996, 7, 1075-1080) 
T he K+, Na+, and Ca2+ channels represent a diverse group of integral membrane proteins [l]. Ion channels regulate the flux of inorganic ions 
across membranes and control the membrane potential 
with high selectivity. Among the most studied ion 
channels are those that which are permeable to Kf 
and are found in the membrane of most animal cells 
(e.g., nerves, lymphocytes, skeletal, and heart muscle 
cells). An important subset of K+ channels is the 
voltage-gated K+ channel (also designated as K VI 
which opens in response to a change in potential 
across the membranes [ll. This opening produces rapid 
and transient electrical excitations across the mem- 
brane and thus facilitates rapid transport of potassium 
ions into the cell. 
In recent years, molecular probes have been identi- 
fied (e.g., drugs, naturally occurring peptidyl toxins) 
which have proven to be useful in elucidating the 
mechanism of action of ion channels [l]. These probes 
generally have been referred to as ion channel blockers 
and they have aided in investigation of the mecha- 
nisms that regulate ion release. For example, several of 
the naturally occurring peptidyl toxins have been 
shown to be potent inhibitors of ion channels 111. 
Margatoxin (MgTX), a 39-residue peptide (Figure 11, 
isolated from the venom of the new world scorpion 
Centruroides marguritutus, was found to block the 
voltage-gated potassium channel, K”1.3 (the number- 
ing is according to the order in which they were 
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discovered) in human peripheral T lymphocytes, with 
high affinity [2, 31. Recently, the purification 121, three 
dimensional structure [4], and structure-activity stud- 
ies of MgTX were reported [3, 51. Furthermore, with 
the introduction of patch clamp techniques, vital infor- 
mation has been provided on the mechanism of inacti- 
vation of ion channels using peptidyl toxins (e.g., 
MgTX) 16, 71. 
The intact ion channel proteins are relatively large 
and too complex for mass spectral analysis. Thus, 
alternative approaches need to be explored in order to 
study the gas-phase noncovalent interactions of these 
proteins with their inhibitors. One approach is to study 
propensities of short peptides, corresponding to the 
selected sequences of the ion channel, to adopt nonco 
valent association with the corresponding inhibitor. 
Utilizing the ion-spray mass spectrometry technique 
(IS-MS), herein we report model studies on gas phase 
non-covalent [8, 91 complexes of MgTX with synthetic 
peptides, which correspond to the proposed high 
affinity binding site of the rat K”1.3. Figure 2 shows a 
simplified schematic diagram of one subunit of a volt- 
age-gated K+ channel (e.g., rat K”1.3). The polypep 
tide chain is comprised of six transmembrane alpha 
helices embedded in the lipid bilayer and referred to 
as segments (S) 1 to 6 [ll. The amino-(N) and carboxy- 
(Cl domains face the cytoplasmic (cell interior) side of 
the membrane. The following peptide fragments, cor- 
responding to the specific domains of the rat K”1.3, 
were synthesized and used in this study: 402-413 (Pl), 
378-384 (P2), 302-315 0’31, 221-235 (P4), and l-15 
(N-terminal domain, designated as P5), Figure 2. Our 
gas-phase data on the binding trends between peptide 
fragments and toxins are in qualitative agreement with 
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Figure 1. Amino acid alignment of toxins margatoxin (MgTXJ, charybdotoxin (ChTXJ, and 
iberiotoxin (IbTX). Brackets indicate the locations of the internal disulfide bridges. MgTX displays 
44% sequence homology with ChTX and 41% with JbTX. 
the ones reported for the intact protein ion-channel 
(vi& irzffa). However, it is important to point out that 
this communication does not take into consideration 
the tertiary structure, solvent interactions, and the in- 
trinsic heterogeneity (e.g., post-translational modifica- 
tions) of the intact ion channel. Furthermore, due to 
lack of a solution phase model of the systems de- 
scribed here, our results do not prove beyond doubt, 
that a specific association exists in solution. In an ideal 
case, mass spectrometry data on noncovalent interac- 
tions should be confirmed by independent studies in 
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the solution phase. Nonetheless, the aim of this effort 
is to explore the utility of a simplified biomimetic 
approach in qualitative characterization (e.g., specific 
vs. nonspecific associations) of peptide-peptide com- 
plexes in the gas phase. 
Experimental 
All experiments were performed on an API III” triple 
quadrupole mass spectrometer (PE-Sciex, Thornhill, 
Ontario, Canada) equipped with an ion-spray (IS) in- 
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Figure 2. A simplified diagram of one subunit of rat voltage-gated K+ channel (e.g., K”1.3). The 
cylinders represent membrane spanning ammo acid sequences, which are proposed to form alpha 
helices. The voltage-gated K+ channel is proposed to consist of four such subunits radially arranged 
around a central hydrophobic pore. Shown are the regions corresponding to residues 402-413 (Pl), 
378-384 (P2),302-315 (P3), 221-235 (P4), and 1-15 (N-terminal domain, designated as I’S). Synthetic 
analogs of these domains were used in this study. The N-terminus of the polypeptide is located in 
the cytosol (separated from the exterior region of the cell by plasma membrane). The pore region 
corresponding to the MgTX binding site, between the transmembrane linker segments S5-S6 (part of 
the pore wall), is indicated by an arrow. MgTX physically plugs the channel “mouth,” in part, by 
specific non-covalent interactions with regions on the extracellular loops, Pl and P2 fragments [2-51. 
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terface. Details of the experimental conditions for ob- 
servation of noncovalent complexes using an API IlI 
(and its up-grade Al? III+) triple quadrupole mass 
spectrometer have been described previously [8]. 
A detailed description for synthesis (using solid 
phase peptide synthesis), chromatographic conditions, 
and purification of MgTX was previously reported 
[lo]. The synthetic MgTX has been shown to be identi- 
cal in physical and biological properties to MgTX pro- 
duced bio-synthetically [lo]. Charybdotoxin (ChTX) 
and iberiotoxin (IbTX) were purchased from Peptide 
International (Louisville, KY). Synthetic analogs of the 
rat K”1.3 peptide ligands were prepared by standard 
solid phase techniques on an ABI 431A peptide synthe- 
sizer. The purity of all samples was examined by 
reversed-phase high performance liquid chromatogra- 
phy and mass spectrometry [lo]. All other chemicals 
and solvents were of reagent grade and were used 
without further purification. Stock solutions of MgTX, 
ChTX, and IbTX were prepared by dissolving 0.1 mg 
of each in 0.5 mL of 10 mM ammonium acetate 
(NH,OAc) buffer (pH - 6.5). Stock solutions (1 
mg/mL) of each synthetic peptide were prepared in 10 
mM NH,OAc and an appropriate aliquot was added 
to the peptidyl toxin solution to reach the desired 
molar ratio. Experiments were performed with 1, 5, 10, 
and 20 molar excess of peptide-to-peptidyl toxin. All 
sample mixtures were incubated for l-2 h at 37°C 
prior to mass spectrometric analysis. 
Results and Discussion 
Figure 3a illustrates the positive ion IS-MS of MgTX. 
The spectrum contains peaks corresponding to the 
charge states 3 + , 4 + , and 5 + of MgTX that were 
used for molecular weight (MW) determination. Satel- 
lite peaks corresponding to the oxidation products [ill 
(e.g., methionine to methionine sulfoxide), potassium, 
and sodium adducts of MgTX were also evident. Addi- 
tion of an approximately equal molar amount of pep- 
tides Pl or P2 (Figure 2, fragments of the outer 
“mouth” of the ion conductance pore) to a solution of 
MgTX resulted in the appearance of new peaks which 
were representative of a 1:l noncovalent association of 
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Figure 3. (al Positive ion IS-MS of synthetically obtained MgTX in 10 mM NH,OAc (pH - 6.51 at 
an orifice voltage of 45 V. Oxidation products (e.g., methionine to methionine sulfoxide), potassium, 
and sodium adducts were observed (satellite peaks). Charge states 3 +, 4 +, and 5 + were used for 
molecular weight deconvolution. f.bl Normalized positive ion IS-MS of MgTX in 10 mM NH,OAc 
(pH - 6.5) at an orifice voltage of 45 V upon incubation with approximately equal molar amount of 
P2 (the I’2 fragment was the base peak in the spectrum obtained for the mixture). Qualitatively 
analoeous results were obtained for MelX:Pl mixture (see Table 11. 
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the MgTX-peptide complexes. For example, Figure 3b 
shows the positive ion IS-MS of MgTX upon incuba- 
tion with P2 peptide at a 1:l molar ratio. Ions corre- 
sponding to 1:l non-covalent complexes for charge 
states 3 + , 4 + , and 5 + were observed. These com- 
plexes underwent dissociation upon increasingly 
“harsh” interface conditions (e.g., orifice potential of 
> 90 V, an increase in the interface temperature, etc.) 
[9] yielding free peptide ligand and MgTX. A decrease 
in the solution pH (e.g., from 7 to 3 by addition of 
acetic acid) afforded similar results. In order to gain 
additional information on the nature of the noncova- 
lent complexes between MgTX and fragments Pl and 
P2, several key experiments (under similar instrumen- 
tal conditions) were performed. 
First, the peptide-to-toxin molar ratio was varied 
and the stoichiometry of the resulting IS-MS spectrum 
was examined. Of specific interest were the type of 
adducts obtained such as AB vs. a random aggregation 
like A,B, AB,, A,, etc. [9a]. Table 1 summarizes the 
IS-MS data obtained for noncovalent complexes be- 
tween the peptidyl toxins and the rat K”1.3 peptide 
ligands under similar experimental conditions. Varia- 
tion in the toxin-to-peptide molar ratio was investi- 
gated as outlined in Table 1. No “false positive” or 
nonspecific aggregation was observed even at 1:20 
toxin-to-peptide ligand molar ratios and higher for Pl, 
P2, and MgTX. 
Second, MgTX was incubated separately with P3, 
P4, and P5 peptides and the resulting IS-MS spectrum 
examined. These peptide fragments are not located at 
the proposed high affinity binding region of the rat 
K”1.3 ion channel (Figure 2) and would not be ex- 
pected to exhibit noncovalent complexation with MgTx. 
As anticipated, mixtures of MgTX with peptides P3, 
P4, and P5 did not result in formation of noncovalent 
complexes (Table 1). 
Third, as additional control experiments, we exam- 
ined the binding specificity of P2 incubated with two 
other high affinity scorpion toxins, charybdotoxin 
(ChTX) and iberiotoxin @TX), which are similar in 
structure to MgTX (Figure 1, Table 1). Despite some 
similarities in channel modulation properties of MgTX, 
J Am Sot Mass Spectrom 1996,7,1075-1080 
IbTX, and ChTX, there are fundamental differences in 
their specific mode of action. ChTX, purified from 
venom of the scorpion Leiurus quinquestriutus, blocks 
with high ‘affinity both the Ca’+-activated and the 
voltage-gated K+ channels (e.g., K “1.3). In contrast, 
IbTX, isolated from venom of the scorpion Buthus 
tanzulus, binds selectively to the high conductance 
Ca’+-activated K+ channel but does not block the 
K”1.3 ion-channel even at high (FM) concentrations 
[12-171. Therefore, lbTX would not be expected to 
form a noncovalent complex with any of the synthetic 
peptide ligands (in particular with Pl and P2). Accord- 
ingly, as shown in Table 1, the IS-MS spectrum of a 
mixture (1:l molar ratio) of IbTX with Pl and P2 did 
not reveal the formation of a noncovalent complex. 
Figures 4a and 4b illustrate the IS-MS of ChTX and 
ChTXP2 (1:l molar ratio), respectively. For the sake of 
clarity, the inset in Figure 4b depicts an expanded m/z 
region corresponding to [ChTX + 4H14+ and [ChTX + 
I’2 + 4H14+ peaks. Ions corresponding to the side 
products (e.g., generated during the synthesis of pep- 
tide ligands) that were not easily separated under 
liquid chromatography conditions were also detected 
(annotated with an asterisk in Figure 4b). 
Fourth, binding of MgTX to a modified P2 ([Lys5]- 
P2) was examined. An alteration in the IS-MS spectra 
upon subtle structural changes in the Pl or P2 peptide 
could yield additional qualitative information on the 
binding specificity of a MgTX-peptide complex. The 
site-directed mutation of the voltage-gated K+ chan- 
nels has been one of the key experiments in mapping 
the binding site for the pore-blocking scorpion toxins 
in the solution phase 1181. Thus, the rationale for syn- 
thesis of [Lys5]-P2 fragment was based on the findings 
reported by McKinnon et al. [18a], where LYS~*~ of the 
Shaker K+ channel (voltage-activated K channel in 
fruit fly Drosophila melunoguster, structurally related to 
the rat and human K”1.3 channels) was replaced by an 
asparagine (which occupies an equivalent position in 
rat K”1.3) or glutamic acid. Position 5 of P2 corre- 
sponded with position 382 of the rat K”1.3 channel 
and with position 427 of the Shaker K+ channel. Due 
to the electrostatic interactions, basic ChTX binds to 
Table 1. Summary of the IS-M!5 data on noncovalent complexes behveen the peptidyl toxins 
and the rat K”1.3 peptide ligands 
Toxin Toxin:Peptide Pl P2 [Lys51-P2 P3 P4 P5 
Mgm 1:l + + - - - 
1:n + + a - - 
ChTX 1:l + + - - 
1 :n + + a - - 
IbTX 1:l - - - - - 
1 :n - a - - - 
In) molar excess of peptide equals 5, 10 and 20 in separate experiments. 
(+I 1:l stoichiometry for noncovalent complexation observed. 
( - 1 noncovalent complexation was not observed at 1 :l , 1:5, 1 :lO, and 1:20 toxin-to-peptide ligand 
molar ratio. 
(a) multiple nonspecific adduction (e.g., up to 2 peptide ligands) for noncovalent complexation 
observed (“false positive”) at 1:20 toxin-to-peptide ligand molar ratio. 
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Figure 4. (a) Positive ion E-MS of commercially obtained ChTX in 10 mM NH,OAc fpH - 6.51 at 
an orifice voltage of 45 V. Charge states 3 +, 4 + and 5 + were used for MW deconvolution (inset). 
tb) Normalized positive ion IS-MS of ChTX in 10 mM NH,OAc (pH - 6.5) at an orifice voltage of 
45 V, upon incubation with approximately equal molar amount of P2 (the P2 fragment was the base 
peak in the spectrum obtained for the mixture). The inset is an expanded region of the spectrum 
from m/z 1050-1300. Qualitatively similar results were obtained for ChTXzPl mixture (see Table 11. 
Annotated with asterisks are the ions that were also observed in the spectrum (control experiment) 
of a stock solution of P2 with no toxin present. 
the modified Shaker channel with higher affinity when attributed to a simple through-space electrostatic re- 
lysine-427 is replaced by an acidic or neutral amino p&ion [lBa]. The P2 peptide fragment of rat K”1.3 
acid. Consequently, a lower binding affinity between was synthesized with asparagine in position 5 replaced 
the peptidyl toxin and the outer “mouth” of the ion by a lysine residue, [Lys51-P2, incubated with each 
conductance pore of wild-type Shaker channel was toxin, and analyzed by IS-MS (Table 1). As expected, 
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the ISMS spectrum of a mixture (1:l molar ratio) of 
MgTX with [Lys’]-P2 did not show the formation of a 
specific noncovalent complex. 
3. Knaus, H-G.; Koch, R. 0. A.; Eberhart, A.; Kaczorowski, G. J.; 
Garcia, M. L.; Slaughter, R. S. Biochemistry 1995, 34, 
13627-13634. 
4. 
Conclusions 5. 
Ion-spray mass spectrometry was utilized to observe 
non-covalent complexes between MgTX and rat K”1.3 
peptide ligands. The data presented in this study indi- 
cated that both specific and nonspecific interactions 
were operative. Similar results were obtained for Pl 
and P2 fragments, which displayed specific 1:l nonco- 
valent association with MgTX. Generally, concentra- 
tion-dependent nonspecific interactions were observed 
in cases where the peptide ligands were not related to 
the Kv1.3 high affinity binding site (the pore region) 
(Table 1). Presently, due to the lack of a solution phase 
model of the aforementioned peptides, the application 
of this approach to unknown systems requires suitable 
control experiments in order to distinguish between 
nonspecific and specific complexes [ 191. Although the 
binding trends discussed in OUT findings are in qualita- 
tive agreement with the studies performed on the 
intact ion-channel proteins, caution should be exer- 
cised in relying solely on the IS-MS data in the absence 
of independent studies in the solution phase. 
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